Monthly Archives: September 2010
EDELRIS collaborates with Merck Serono
EDELRIS has announced that it has signed collaboration with Merck Serono aiming at the delivery of innovative and exclusive chemical entities for Fragment-Based Drug Discovery. EDELRIS has previously signed collaborations with Galapagos and Roche.
Filed under alliances
Rigel Pharmaceuticals receives $25 million milestone from AstraZeneca
Rigel Pharmaceuticals has announced that it has received a $25 million milestone payment from AstraZeneca. The payment comes from the fulfillment of two major milestones regarding the clinical development of fostamatinib (R788). The first milestone is for initiation of the … Continue reading
Filed under alliances
MediGene halves workforce
MediGene has announced a significant restructuring of its business as a result of which the total number of staff employed by the company will be reduced from 107 to approximately 55. The majority of the redundancies will come from the … Continue reading
Filed under funding
Ligon Discovery collaborates with Bayer Schering Pharma
Ligon Discovery has announced that it has partnered with Bayer Schering Pharma to apply its small molecule microarray screening platform to discover drug candidates for new disease targets in the fields of oncology and coagulation disorders.
Filed under alliances
KINAXO and Daiichi Sankyo sign collaboration agreement
KINAXO Biotechnologies and Daiichi Sankyo have entered a long-term partnership in cancer research. Under the agreement, Daiichi Sankyo will employ KINAXO’s technology platform to support the development of Daiichi Sankyo’s targeted cancer drugs. This will involve KINAXO applying its pchemical … Continue reading
Filed under alliances
GENOVAC announces antibody discovery collaboration with ESBATech
GENOVAC has announced that it has entered into a research collaboration with ESBATech, a subsidiary of Alcon, for the generation of antibodies for use in the field of ophthalmology. Under the terms of the agreement, GENOVAC will apply its genetic … Continue reading
Filed under alliances
Dyax and CMIC sign DX-88 partnership
Dyax and CMIC have announced an agreement to develop and commercialize subcutaneous DX-88 for the treatment of hereditary angioedema and other angioedema indications in Japan. DX-88 has been approved by the FDA and is marketed for the treatment of acute … Continue reading
Filed under alliances
Human Genome Sciences selects monoclonal antibody in Morphotek collaboration
Morphotek, a subsidiary of Eisai, has announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences. Under the agreement, the parties collaborate in the … Continue reading
Filed under alliances
Clinical Genomics and Garvan sign license agreement for bio-markers
Clinical Genomics and The Garvan Institute of Medical Research, an institute focused on gene-based medical research with a strong focus on cancer and metabolic syndromes, both based in Sydney, Australia, have entered into a license agreement in relation to novel … Continue reading
Filed under alliances
Pieris signs collaboration with Sanofi-Aventis
Pieris has announced that it has signed a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group under which Pieris will apply its Anticalin technology to discover novel Anticalin drugs against multiple … Continue reading
Filed under alliances
